<ul data-eligibleForWebStory="true">Cancer rates rising in the U.S., vary by state, impacting survival outcomes.Oncolytics Biotech Inc. leads the charge with promising virus-based immunotherapy developments.Survival data show significant progress in treating hard-to-treat cancers like mPDAC, and mBC.